# A Study to Assess Ulimorelin in Healthy Subjects

> **NCT02993055** · PHASE1 · COMPLETED · sponsor: **Lyric Pharmaceuticals** · enrollment: 39 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Ulimorelin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02993055
- **Lead sponsor:** Lyric Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02993055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02993055, "A Study to Assess Ulimorelin in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02993055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*